VHP Banner

BV+ Report - FINAL

PathGroup’s new Vaginal Health Portfolio utilizes the most advanced PCR technology, providing accurate and actionable answers in less time for the most common infections of the genital tract. And with a dedicated panel for Bacterial Vaginosis, you’ll gain valuable insights into your patient’s vaginal ecosystem for more targeted and effective management.

PathGroup’s Vaginal Health Portfolio is comprised of tailored, infection-specific panels providing clinically relevant and actionable results for:

  • Bacterial Vaginosis+
  • Candida
  • Leukorrhea
  • Vaginitis
  • Aerobic Vaginitis
  • Genital Ulcer

Early & Accurate Detection

  • Industry leading turnaround times
  • 31 organisms providing superior sensitivity and specificity
  • Clinically relevant, infection-specific panels
  • Single sample, convenient collection

In-Network Strategy

  • All insurances accepted – preferred provider status with an extensive payer list
  • Over 98% of claims are processed in-network annually
  • Meaningful, cost-conscience test utilization

Innovative Technology, Actionable Results

  • Tailored, clinically relevant panels focused on key infectious organisms
  • Advanced PCR technology for quantitative results
  • Straightforward reports with simple informatics and clinically actionable data
  • HL7-compliant reports for ease of use and interpretation


To partner with PathGroup, call 800.366.5847 or email marketing@pathgroup.com for more information.